EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer model

Ki-Hyun Kim, Seung-Jae Kim, Jacob D Eccles, Christian Ascoli, Gye Young Park

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03828-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Ki-Hyun Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, 840 S. Wood St. CSB-920N, M/C719,…. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Dendritic Cells, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NHLBI NIH HHS, The U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human lung cancer carries high genetic alterations, expressing high tumor-specific neoantigens. Although orthotopic murine lung cancer models recapitulate many characteristics of human lung cancers, genetically engineered mouse models have fewer somatic mutations than human lung cancer, resulting in scarce immune cell infiltration and deficient immune responses. The endogenous mouse lung cancer model driven by Kras mutation and Trp53 deletion (KP model) has minimal immune infiltration because of a scarcity of neoantigens. Fine-tuning tumor antigenicity to trigger the appropriate level of antitumor immunity would be key to investigating immune responses against human lung cancer. We engineered the KP model to express antigens of OVA peptides (minOVA) as neoantigens along with ZsGreen, a traceable fluorescent conjugate. The KP model expressing minOVA exhibited stronger immunogenicity with higher immune cell infiltration comprised of CD8 + T cells and CD11c + dendritic cells (DCs). Consequently, the KP model expressing minOVA exhibits suppressed tumor growth compared to its origin. We further analyzed tumor-infiltrated DCs. The majority of ZsGreen conjugated with minOVA was observed in the conventional type 2 DCs (cDC2), whereas cDC1 has minimal. These data indicate that tumor immunogenicity regulates host immune responses, and tumor neoantigen is mostly recognized by cDC2 cells, which may play a critical role in initiating antitumor immune responses in an orthotopic murine lung cancer model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmDendritic CellsLung NeoplasmsAnimalsFemaleHumansMiceCD8-Positive T-LymphocytesCell Line, TumorDisease Models, AnimalMice, Inbred C57BLMice, Transgenic

Stichwörter der Autor:innen

Conventional dendritic cell type 2Lung cancerNeoantigenOrthotopic lung cancer model

Substanzen

Antigens, Neoplasm

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, 840 S. Wood St. CSB-920N, M/C719, Chicago, IL, 60612, USA.
  • Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, 840 S. Wood St. CSB-920N, M/C719, Chicago, IL, 60612, USA. parkgy@uic.edu.
  • Jesse Brown Veterans Affairs Medical Center, Chicago, IL, USA. parkgy@uic.edu.

Förderung

  • BLRD VA
  • NHLBI NIH HHS
  • The U.S. Department of Veterans Affairs
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Kim, K. H., Kim, S. J., Eccles, J. D., Ascoli, C., & Park, G. Y. (2024). Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer model. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03828-w

Vancouver

Kim KH, Kim SJ, Eccles JD, Ascoli C, Park GY. Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer model. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03828-w

BibTeX
@article{Kim2024,
  author = {Kim, Ki-Hyun and Kim, Seung-Jae and Eccles, Jacob D and Ascoli, Christian and Park, Gye Young},
  title = {Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer model},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03828-w}
}
Kostenlos starten →